ReportWire

Tag: drugs in sports

  • Investigation launched after death of Navy Seal candidate prompts overhaul of how ‘Hell Week’ training course is monitored | CNN Politics

    Investigation launched after death of Navy Seal candidate prompts overhaul of how ‘Hell Week’ training course is monitored | CNN Politics

    [ad_1]



    CNN
     — 

    Inadequate medical screening and uninformed medical staff contributed to the death of a Navy SEAL candidate hours after he had completed a brutal part of the training course known as “Hell Week,” a Navy investigation found.

    The investigation prompted an overhaul of how the Navy monitors one of the military’s most brutal and demanding processes.

    It found that the medical support for the Basic Underwater Demolition/Sea Air and Land course was “poorly organized, poorly integrated, and poorly led,” wrote Rear Adm. Peter Garvin, the commander of Naval Education and Training Command. The lack of proper medical care “put candidates at significant risk.”

    Garvin also said that additional accountability measures are necessary in the wake of the failures that contributed to Mullen’s death. According to a Navy official, Garvin recommended considering accountability actions against approximately 10 people. A Navy regional legal service office is reviewing the investigation and will make recommendations about accountability, the official said, after which the command will decide what actions to take.

    The training and selection course is designed to push SEAL candidates to the limit and beyond, creating an environment where only the most qualified and capable will finish, but Garvin said there must still be “effective risk management” to prevent injuries and illness during the high-risk training.

    In February 2022, Navy SEAL candidate Kyle Mullen had just completed Hell Week and underwent a final medical check before he went to rest at his barracks. The investigation found Mullen had suffered respiratory issues during the arduous training, but information about the symptoms was not passed on to the Navy’s medical clinic, leading them to conclude he was not at risk.

    Eight hours later, Mullen was pronounced dead.

    In the hours before his death, Mullen was coughing up an “orange-red fluid” and having trouble breathing, according to the investigation. Even as he repeatedly refused advanced medical care, he appeared to be choking on his words and gasping for air as if he was drowning. But the personnel assigned to check on Mullen and other SEAL candidates, known as watch standers, had no medical or emergency care training.

    Candidates going through Hell Week are normally given a form of penicillin called Bicillin at the start of the course to reduce the risk of bacterial pneumonia. But the investigation found Mullen never received the preventative medicine, likely because there was a shortage at the time.

    In the end, the investigation found “failures across multiple systems” that put candidates at a high risk of serious injury, Garvin wrote.

    “Our effectiveness as the navy’s maritime special operations force necessitates demanding, high-risk training,” said Rear Adm. Keith Davids, the commander of Naval Special Warfare Command, at the conclusion of the investigation. “While rigorous and intensely demanding, our training must be conducted with an unwavering commitment to safety and methodical precision.”

    In October, following a separate investigation that focused specifically on Mullen’s death, the Navy took administrative actions against the former commanding officer of Basic Training Command, Capt. Bradley Geary; the commander of Naval Special Warfare Center, Capt. Brian Drechsler; and senior medical staff under their command. An administrative action is typically in the form of a letter to the service member instructing them on correcting deficient performance.

    Earlier this month, Drechsler was removed from his job two months early.

    Following Mullen’s death, the Navy revamped how it handles medical screening during the training and selection process. The Navy bolstered medical oversight during and after the Hell Week course, requiring medical screenings every 24 hours.

    Candidates now recover from the course in a center located very close to the medical clinic, allowing more thorough observation at a critical time, and the leading watch stander is a qualified high-risk instructor. In addition, a medical officer must be at the Naval Special Warfare Center Medical Department during all of Hell Week to evaluate candidates going through the course.

    The investigation also looked at how to handle the use of performance enhancing drugs (PEDs) during the course. In September, a naval special warfare senior officer who spoke to CNN on condition of anonymity said there is “beyond a reasonable doubt that a significant portion of the candidate population is utilizing a wide range of performance enhancing drugs.”

    A search of Mullen’s car after his death found packages labeled “Big Genes Recombinant Human Growth Hormone” and “Testosterone Cypionate,” a type of steroid. But Mullen was not tested after his death for the PEDs because of the need for a blood and urine sample.

    Other members of Mullen’s class told investigators they felt there was an implicit endorsement of the use of PEDs after an instructor told the candidates, “Don’t use PEDs, it’s cheating, and you don’t need them. And whatever you do, don’t get caught with them in your barracks room.”

    After Mullen’s death, the Navy received from the Defense Department an expanded authority to test Naval Special Warfare Candidates for PEDs. All candidates going through the SEALs course and the Special Warfare Combatant-Craft Crewman course are subject to random drug testing.

    This story has been updated with additional details.

    [ad_2]

    Source link

  • WADA appeals case of Russian figure skater Kamila Valieva to Court of Arbitration for Sport | CNN

    WADA appeals case of Russian figure skater Kamila Valieva to Court of Arbitration for Sport | CNN

    [ad_1]



    CNN
     — 

    The protracted doping saga involving Russian figure skater Kamila Valieva entered another phase on Tuesday as the World Anti-Doping Agency (WADA) appealed the case to the Court of Arbitration for Sport (CAS).

    Last month, the Russian Anti-Doping Agency (RUSADA) effectively cleared Valieva of wrongdoing, saying that the 16-year-old had violated anti-doping rules but bore no “fault or negligence” for the transgression.

    But WADA believes such a conclusion is “wrong” and has now exercised its right to appeal the ruling.

    Valieva was suspended by RUSADA the day after she guided the Russian Olympic Committee (ROC) to victory in the figure skating team event at last year’s Winter Olympics in Beijing, where she also became the first woman in history to land a quadruple jump at the Games.

    However, it came to light during the course of the Olympics that Valieva had tested positive for the heart medication trimetazidine – which can enhance endurance – in December 2021.

    Valieva has not publicly explained the positive test results.

    The ROC placed first in the team event in Beijing ahead of the USA in second, Japan in third and Canada in fourth, but no medal ceremony was held as a result of the doping controversy.

    In a statement on Tuesday, WADA said it is seeking a four-year period of ineligibility for Valieva and disqualification of her results from the date of the sample collection on December 25, 2021.

    “As it has sought to do throughout this process, WADA will continue to push for this matter to proceed without further undue delay,” the statement added.

    “Given the case is now pending before CAS, WADA can make no further comment at this time.”

    CNN has contacted RUSADA and the International Olympic Committee for comment.

    Valieva was cleared to compete in the women’s singles event at the Winter Olympics but ultimately placed fourth after falling and stumbling several times during the competition.

    Travis Tygart, the CEO of the US Anti-Doping Agency (USADA), said on Tuesday that the decision to appeal Valieva’s case to CAS “had to be done in order to restore some confidence in the global anti-doping system.”

    He added: “Let’s hope the hearing is expedited and open to the public so that the athletes whose dreams are hanging in the balance can believe in the final outcome, whatever it may be, and that some justice can be salvaged soon.”

    [ad_2]

    Source link

  • Russian figure skater Kamila Valieva cleared by RUSADA, WADA to review doping decision and consider appeal | CNN

    Russian figure skater Kamila Valieva cleared by RUSADA, WADA to review doping decision and consider appeal | CNN

    [ad_1]



    CNN
     — 

    The Russian Anti-Doping Agency (RUSADA) found figure skater Kamila Valieva violated anti-doping rules but bore no “fault or negligence” for the transgression, according to the World Anti-Doping Agency (WADA).

    The ruling in effect clears Valieva of wrongdoing and administers no punishment beyond the disqualification of her results from December 25, 2021 – the date of her sample collection.

    The decision, made by a RUSADA tribunal, would allow the Russian Olympic Committee (ROC) to earn the gold medals won in the team figure skating event at the Beijing Olympics in 2022.

    CNN has reached out to RUSADA for comment.

    The World Anti-Doping Agency (WADA) released a statement implying it is likely to appeal the verdict.

    “WADA notes this outcome and has requested a copy of the full reasoned decision, which it will review together with the case file in order to determine whether the ruling is in line with the terms of the World Anti-Doping Code,” it said in a statement.

    “However, based on the elements of the case with which WADA is already familiar, the Agency is concerned by the finding of ‘no fault or negligence’ and will not hesitate to exercise its right of appeal to the Court of Arbitration for Sport, as appropriate.

    “Following a full review of the RUSADA decision, WADA will consider what its next steps will be so that the matter is dealt with as quickly as possible and without further undue delay.”

    Travis Tygart, CEO of the US Anti-Doping Agency (USADA), said in a statement to CNN: “WADA and the ISU [International Skating Union] have to appeal this decision, for the sake of the credibility of the anti-doping system and the rights of all athletes.

    “The world can’t possibly accept this self-serving decision by RUSADA, which in the recent past has been a key instrument of Russia’s state sponsored doping fraud and is non-compliant. Justice demands a full, fair, public hearing outside of Russia.”

    Valieva, who is now 16, was suspended by RUSADA the day after she guided the Russian Olympic Committee (ROC) to victory in the team event in Beijing, where she became the first woman to land a quadruple jump in the Winter Olympics.

    She tested positive for a banned substance – the heart medication trimetazidine, which can enhance endurance – in December 2021. But the results of the failed December drug test only came to light during the Olympics when it was analyzed and reported to RUSADA.

    Valieva has not publicly explained the positive test results.

    Team USA finished second in the team event in Beijing, Japan in third, and Canada fourth. As a result of the doping controversy, no medal ceremony was held during the Games.

    CNN has reached out to the ISU and the International Olympic Committee (IOC) for comment.

    In a statement to CNN, the US Olympic and Paralympic Committee said: “As we approach the one-year anniversary of the Beijing Games, it remains very important that the figure skating team event athletes who competed in Beijing get the resolution they deserve.

    “We thank WADA for their commitment to reviewing this issue and moving the process forward as expeditiously as possible.”

    [ad_2]

    Source link